News Hangzhou Tigermed Consulting Co., Ltd OTC Markets

Equities

HNGZY

US41044T1088

Market Closed - OTC Markets Other stock markets 11:43:36 2023-12-19 am EST			5-day change	1st Jan Change
4.2 ^USD	-4.55%		-.--%	-.--%

Apr. 25	Hangzhou Tigermed Consulting’s Profit Down 59% in Q1	MT
Apr. 25	Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hangzhou Tigermed Consulting’s Profit Down 59% in Q1	Apr. 25	MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024	Apr. 25	CI
Tigermed Consulting's Profit, Revenue Climb in 2023	Mar. 29	MT
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024	Mar. 28	CI
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes	Mar. 21	CI
China Healthcare Stocks Rally on Hopes for Government Support	Mar. 14	DJ
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares	Mar. 14	RE
Nomura Downgrades Hangzhou Tigermed Consulting to Neutral From Buy, Adjusts Price Target to 49.61 Yuan From 75.72 Yuan	Mar. 05	MT
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to HK$32.69 From HK$57.77	Mar. 05	MT
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%	Feb. 07	MT
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.	Feb. 06	CI
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.	Feb. 05	CI
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to 75.72 Yuan from 83.50 Yuan, Keeps at Buy	23-10-30	MT
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to HK$57.77 from HK$64.46, Keeps at Buy	23-10-30	MT
Hangzhou Tigermed Consulting's Profit Up 19% in Q3	23-10-27	MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Tigermed Reports 2023 Interim Results	23-08-28	AQ
Tigermed Consulting's Profit Jumps 16.5% in H1	23-08-28	MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hangzhou Tigermed Consulting Co., Ltd OTC Markets

Equities

HNGZY

US41044T1088

Summary

Filters